Cargando…
Unraveling the therapeutic potential of the LncRNA-dependent noncanonical Hedgehog pathway in cancer
Acquired resistance to Hedgehog pathway inhibitors has been reported in the clinical setting and upregulation of noncanonical Hedgehog signaling is one of the major underlying mechanisms behind this resistance. As demonstrated in our recent study, greater clinical efficacy might be achieved by focus...
Autores principales: | Xing, Zhen, Lin, Chunru, Yang, Liuqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905365/ https://www.ncbi.nlm.nih.gov/pubmed/27308519 http://dx.doi.org/10.1080/23723556.2014.998900 |
Ejemplares similares
-
The pan-cancer lncRNA MILIP links c-Myc to p53 repression
por: Feng, Yu Chen, et al.
Publicado: (2020) -
Hedgehog-targeted therapeutics uncouple the vicious cycle of bone metastasis
por: Hurchla, Michelle A., et al.
Publicado: (2012) -
The hedgehog’s trick for escaping immunosurveillance: The molecular mechanisms driving myeloid-derived suppressor cell recruitment in hedgehog signaling-dependent tumors
por: Xie, Jingwu
Publicado: (2014) -
LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy
por: Egranov, Sergey D., et al.
Publicado: (2020) -
Sonic Hedgehog factor Gli1: As good as resistant
por: Zahreddine, Hiba Ahmad, et al.
Publicado: (2015)